Hannu Lång
Terveys, väestönmuutos ja hyvinvointi Horisontti 2020 ohjelmassa Tästä se lähtee – Tietoa Horisontti 2020 rahoituksesta (Otaniemi, 27.11.2013) Hannu Lång, Unit of Infectious Diseases & Public Health, Health Directorate Directorate-General for Research and Innovation European Commission Research and Innovation Esityksen pääkohdat FP7: Suomen menestys edellisessä puiteohjelmassa Horisontti 2020:–ohjelman ydin Terveys, väestönmuutos ja hyvinvointi : Työohjelma 20142015. Research and Innovation Health EU RTD Landscape •Alzheimer •Agriculture, Food Security & Climate change •Health and Diet •Cultural Heritage ERANET+ ERANET Ageing (More Years Better Lives) Climate Knowledge (Clik-EU) Seas and Oceans Antimicrobial resistance Urban Europe Water challenges JTI Artemis Eniac Clean Sky IMI FCH ICT-FET (Flag Ships) Fundamental Research ERC JTI PPP SMEs and SME Associations PEOPLE Development eHealth eIdentity ICT for TT Energy efficiency A Pilots PPP Energy Efficient Buildings Future of Factories Smart grid & Utilities Green cars Future Internet TT, mobility & logistics Content Environment & Smart Food Safe Cities Large Scale Demos & Trials Innovation Deployment Market set up 15/02/2011 * EERP – European Energy Recovery Plan XII/2010 8IPx5M€x2 years NER300 – New Entrants Reserve 300 Million Tons Research and X/2012 5IPx13,5 M€x2 years demonstration site Innovation Autor: Serafín de la Concha (CDTI) EII on Energy EUROSTARS INFRASTRUCTURES Applied Research Art. 185 AAL Bonus EMRP, EDCTP Programmes Wind EWI ≈6B€ Instruments Solar SEII ≈16B€ Bioenergy EIBI≈9 B€ New thematic Carbon Capture & Storage ≈13B€ initiatives Electricity Grid EEGI≈ 2 B€ Sustainable Nuclear ESNII ≈10 B€ Smart Cities (E2B+TT+Grid)≈11B€ Suomalaisten menestys FP7 Research and Innovation Research and Innovation Research and Innovation Research and Innovation Horisontti 2020 pähkinänkuoressa Research and Innovation Mikä on Horisontti 2020 • €70 miljardia EUn tutkimukseen ja innovaatioon 2014-2020 • Ydinosa 'Europe 2020, Innovation Union & European Research Area': − Vastaus talouskriisiin; investointi tulevaisuuden työpaikkoihin ja kasvuun − Vastaus ihmisten huoleen toimeentulosta, turvallisuudesta ja ympäristöstä − EU’s globaalisen aseman vahvistaminen tutkimuksessa, innovaatiossa ja teknologiassa Research and Innovation Mitä on uutta? • Yksi ohjelma tuo yhteen kolme erillistä ohjelmaa/aloitetta* • Tutkimuksen ja innovaation kytkentä – tutkimuksesta myyntiin, innovaatio laajasti ymmärrettynä • Polttopisteessä yhteiskunnalliset haasteet esim. terveys, puhdas energia ja liikenne • Yksinkertaistettu hakumenettely, kaikille yrityksille, yliopistoille, instituuteille EU maissa ja muualla ⃰ The 7th Research Framework Programme (FP7), innovation aspects of Competitiveness and Innovation Framework Programme (CIP), EU contribution to the European Institute of Innovation and Technology (EIT) Research and Innovation Mitä muuta on uutta? • Uusi tasapaino luottamuksen ja kontrollin välillä – vähemmän tilintarkastuksia • Rahoitussopimuksilla yksinkertaisemmat säännöt • Sivukulut lasketaan kaikille samoin (25%) • Uusia rahoitusmuotoja innovaatioon ja PKyrityksille • Nopeampi hakemusten arviointi ja sopimusneuvottelu (< 8kk) Research and Innovation Helpot sopimukset: 100% kuluista korvataan (paitsi What else is new innovaatiotoimissa, joissa 70% max korvataan voittoa tekevissä • New balance between trust and control – osallistujissa) fewer audits Sivukulut: 25% hyväksyttävistä suorista kustannuksista • Simpler rules for grants • Indirect costs calculated with a single flat rate • New forms of funding aimed at innovation and focused funding for SMEs • Successful projects up and running more quickly Research and Innovation UUsi 'PK instrumentti' ~5 miljardia EUR H2020ssa What else is new US "SBIR" mallin inspiroima Haasteiden ohjaama, 'bottom up' • New balance between trust and control – fewer audits Yksittäinen yritys voi saada rahoituksen: • Simpler rules for grants 3 vaihetta / 3 entry points: Konseptin arviointi, ja flat • Indirect costs calculated with atutkimus single innovaatio demonstrointi, rate kaupallistaminen • New forms of funding aimed at innovation and focused funding for SMEs • Successful projects up and running more quickly Research and Innovation Eurooppa 2020 prioriteetit Yhteiset tavoitteet ja periaatteet Samat säännöt, työkalupakki rahoitusmuodoille Yhteiskunnalliset haasteet Tutkimuksen ohjaamat projektit Teollisuuden johtoasema Huipputason tiede Tavoitteiden tukeminen: EIT JRC Research and Innovation Markkinoiden ohjaamat projektit Laajat hakuaiheet Vähemmän yksityiskohtia hakuaiheissa Horisontaaliset hakuaiheet Kaksivuotinen työohjelma Suurempi paino loppukäyttäjillä Research and Innovation Recap: the 'Health, demographic change and wellbeing' challenge Proposed funding 2014-2020 (million EUR) Research and Innovation The Work Programme 2014/15 in brief Call 'personalising health and care' 34 topics (15 in 2014, 17 in 2015, 2 open in both years) Call for 'co-ordination activities' 16 topics (11 in 2014, 5 in 2015) € 1,21 billion Research and Innovation 7 Focus Areas Understanding health, ageing & disease Effective health promotion, disease prevention, preparedness and screening Improving diagnosis Innovative treatments and technologies Advancing active and healthy ageing Integrated, sustainable, citizen-centred care Improving health information, data exploitation and providing an evidence base for health policies and regulation Research and Innovation Understanding the call topics: example • 'PHC 2 – 2015' • 'Specific challenge' • 'Scope' • 'Expected impact' • 'Type of action' Research and Innovation Personalising Health and Care Research and Innovation Unravelling health and disease • Determinants, risk factors and pathways of diseases (2014) • Determinants and pathways of healthy and active ageing (2014) • Systems medicine approaches (2015) • Common mechanisms of diseases and potential co-morbidities (2015) Research and Innovation From "omics" … to prevention • Inter-sector cooperation for environment- and healthbased interventions (2015) • Translating -omics into prevention and health promotion (2014) • Evaluating existing screening and prevention programmes (2014) • Control of infectious epidemics through rapid pathogen identification (2014) • Vaccine platforms for TB (2014) and HIV (2015) Research and Innovation In biomarkers we trust … and in novel diagnostic tools • In vitro devices, assays and platforms (2014) • In vivo medical imaging technologies (2015) • Clinical validation of biomarkers (2014, 2015) • SME focus Research and Innovation Finding the cure … and evaluating existing treatments • Therapies for non-communicable diseases (2014) and rare diseases (2015) • Tools and technologies for advanced therapies (2015) • Clinical research on regenerative medicine (2014) • Comparing and establishing effectiveness of health interventions in the elderly (2014) and children (2015) Research and Innovation Adding more life to our years • Service robotics within assisted living environments (2014) • Solutions for independent living (2014) • Early risk detection and intervention (2015) • Promoting mental wellbeing in the ageing population (2015) Research and Innovation • • The citizen in the centre New models for prevention oriented health and care systems (2014) • Piloting personalised medicine in health and care systems (2015) • Self-management of health and disease: mHealth, ICT, decision support systems • Public procurement and eHealth • eHealth sectorial inducement prize Research and Innovation • • The citizen in the centre (2) ICT systems for integrated care (2015) • Citizen support and mHealth (2014) • Self-management by predictive computer modelling (2015) • Patient empowerment by ICT (2015) • Public procurement and eHealth (2015) Research and Innovation Big Data for research • Digital representation of health data to improve diagnosis and treatment (2015) • Foresight for health policy development and regulation (2014) • Advancing bioinformatics for clinical needs (2014) • Improve predictive human safety testing (2015) • eHealth interoperability (2014) Research and Innovation Co-ordination activities Research and Innovation Support for European and International Initiatives • European Innovation Partnership on Active and Healthy Ageing • Global Alliance for Chronic Diseases (GACD) – Diabetes (2014) • Joint Programming Initiative 'More Years, Better Life's (2014) • Joint Programming Initiative on neurodegenerative diseases (JPND, 2014) • Global Research Collaboration for Infectious Disease Preparedness (2014) • European Reference Networks (2015) Research and Innovation Completing the European Research Area • Joint Programming Initiative on neurodegenerative diseases (JPND, 2014) • Translational cancer research (2014) • Systems medicine for clinical needs (2014) • Rare diseases (2014) • 2015: Brain-related disorders, antimicrobial resistance, cardiovascular diseases Research and Innovation Strategic Initiatives Innovative Medicines Initiative 2 www.imi.europa.eu European Innovation Partnership on Active and Healthy Ageing https://webgate.ec.europa.eu/eip aha Active and Assisted Living 2 www.aal-europe.eu European & Developing Countries Clinical Trials Partnership (EDCTP2) www.edctp.org Research and Innovation Thank you [email protected] www.ec.europa/research/horizon2020 Research and Innovation
© Copyright 2025